Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 


 

FORM 10-Q

 


 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2004

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission file number 0-7154

 


 

QUAKER CHEMICAL CORPORATION

(Exact name of Registrant as specified in its charter)

 


 

Pennsylvania   23-0993790

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

One Quaker Park, 901 Hector Street,

Conshohocken, Pennsylvania

  19428 – 0809
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: 610-832-4000

 

Not Applicable

Former name, former address and former fiscal year, if changed since last report.

 


 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes  x    No  ¨

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Number of Shares of Common Stock

Outstanding on July 31, 2004

  9,656,715

 



Table of Contents

QUAKER CHEMICAL CORPORATION AND CONSOLIDATED SUBSIDIARIES

 

PART I.

  FINANCIAL INFORMATION     

Item 1.

  Financial Statements (unaudited)     
    Condensed Consolidated Balance Sheet at June 30, 2004 and December 31, 2003    3
    Condensed Consolidated Statement of Income for the Three and Six Months ended June, 2004 and 2003    4
    Condensed Consolidated Statement of Cash Flows for the Six Months Ended June 30, 2004 and 2003    5
    Notes to Condensed Consolidated Financial Statements    6

Item 2.

  Management’s Discussion and Analysis of Financial Condition and Results of Operations    13

Item 3.

  Quantitative and Qualitative Disclosures About Market Risk    18

Item 4.

  Controls and Procedures    18

PART II.

  OTHER INFORMATION     

Item 4.

  Submission of Matters to a Vote of Security Holders    19

Item 6.

  Exhibits and Reports on Form 8-K    19

Signature

   20

 

* * * * * * * * * *

 

2


Table of Contents

Item 1. Financial Statements

 

Quaker Chemical Corporation

 

Condensed Consolidated Balance Sheet

 

    

Unaudited

(Dollars in thousands, except par
value and share amounts)


 
    

June 30,

2004


   

December 31,

2003*


 

ASSETS

                

Current assets

                

Cash and cash equivalents

   $ 24,470     $ 21,915  

Accounts receivable, net

     81,791       78,121  

Inventories

                

Raw materials and supplies

     18,781       14,691  

Work-in-process and finished goods

     19,069       17,520  

Prepaid expenses and other current assets

     14,442       11,277  
    


 


Total current assets

     158,553       143,524  
    


 


Property, plant and equipment, at cost

     138,565       136,448  

Less accumulated depreciation

     76,619       74,057  
    


 


Net property, plant and equipment

     61,946       62,391  

Goodwill

     32,906       33,301  

Other intangible assets, net

     8,996       9,616  

Investments in associated companies

     5,923       6,005  

Deferred income taxes

     12,839       12,846  

Other assets

     19,718       19,664  
    


 


Total assets

   $ 300,881     $ 287,347  
    


 


LIABILITIES AND SHAREHOLDERS’ EQUITY

                

Current liabilities

                

Short-term borrowings and current portion of long-term debt

   $ 54,164     $ 42,992  

Accounts and other payables

     42,017       41,259  

Accrued compensation

     6,138       6,816  

Other current liabilities

     13,305       14,738  
    


 


Total current liabilities

     115,624       105,805  

Long-term debt

     17,946       15,827  

Deferred income taxes

     2,764       2,688  

Other noncurrent liabilities

     41,564       40,967  
    


 


Total liabilities

     177,898       165,287  
    


 


Minority interest in equity of subsidiaries

     11,021       9,708  
    


 


Shareholders’ equity

                

Common stock $1 par value; authorized 30,000,000 shares; issued (including treasury shares) 9,664,009 shares

     9,664       9,664  

Capital in excess of par value

     2,489       2,181  

Retained earnings

     119,316       117,308  

Unearned compensation

     (488 )     (621 )

Accumulated other comprehensive (loss)

     (18,790 )     (15,406 )
    


 


       112,191       113,126  

Treasury stock, shares held at cost; 2004 – 8,832, 2003 – 54,178

     (229 )     (774 )
    


 


Total shareholders’ equity

     111,962       112,352  
    


 


     $ 300,881     $ 287,347  
    


 



* Condensed from audited financial statements.

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3


Table of Contents

Quaker Chemical Corporation

 

Condensed Consolidated Statement of Income

 

    

Unaudited

(dollars in thousands, except per share data)


 
    

Three Months ended

June 30,


   

Six Months ended

June 30,


 
     2004

    2003

    2004

    2003

 

Net sales

   $ 98,683     $ 83,453     $ 196,814     $ 156,790  

Cost of goods sold

     66,139       54,506       131,815       99,477  
    


 


 


 


Gross margin

     32,544       28,947       64,999       57,313  

Selling, general and administrative expenses

     27,209       23,223       53,807       45,908  
    


 


 


 


Operating income

     5,335       5,724       11,192       11,405  

Other income (expense), net

     208       447       767       535  

Interest expense

     (547 )     (387 )     (1,017 )     (737 )

Interest income

     198       152       353       363  
    


 


 


 


Income before taxes

     5,194       5,936       11,295       11,566  

Taxes on income

     1,636       1,843       3,558       3,701  
    


 


 


 


       3,558       4,093       7,737       7,865  

Equity in net income of associated companies

     186       169       335       255  

Minority interest in net income of subsidiaries

     (897 )     (787 )     (1,916 )     (1,538 )
    


 


 


 


Net income

   $ 2,847     $ 3,475     $ 6,156     $ 6,582  
    


 


 


 


Per share data:

                                

Net income – basic

   $ 0.30     $ 0.37     $ 0.64     $ 0.71  

Net income – diluted

   $ 0.29     $ 0.36     $ 0.62     $ 0.69  

Dividends declared

   $ 0.215     $ 0.21     $ 0.43     $ 0.42  

Based on weighted average number of shares outstanding:

                                

Basic

     9,604,142       9,323,895       9,587,393       9,297,482  

Diluted

     9,983,809       9,671,578       9,981,999       9,593,466  

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4


Table of Contents

Quaker Chemical Corporation

 

Condensed Consolidated Statement of Cash Flows

 

    

Unaudited

(Dollars in thousands)

For the Six Months Ended
June 30,


 
     2004

    2003

 

Cash flows from operating activities

                

Net income

   $ 6,156     $ 6,582  

Adjustments to reconcile net income to net cash (used in) operating activities:

                

Depreciation

     4,098       3,394  

Amortization

     575       438  

Equity in net income of associated companies

     (335 )     (255 )

Minority interest in earnings of subsidiaries

     1,916       1,538  

Deferred compensation and other, net

     245       226  

Pension and other postretirement benefits

     411       2,190  

Increase (decrease) in cash from changes in current assets and current liabilities, net of acquisitions:

                

Accounts receivable

     (4,824 )     (11,380 )

Inventories

     (6,110 )     (2,789 )

Prepaid expenses and other current assets

     (3,318 )     1,204  

Accounts payable and accrued liabilities

     (213 )     (2,467 )

Change in restructuring liabilities

     (327 )     (866 )
    


 


Net cash (used in) operating activities

     (1,726 )     (2,185 )
    


 


Cash flows from investing activities

                

Investments in property, plant and equipment

     (4,915 )     (4,859 )

Dividends and distributions from associated companies

     233       3,890  

Payments related to acquisitions

     —         (1,105 )

Other, net

     28       53  
    


 


Net cash (used in) investing activities

     (4,654 )     (2,021 )
    


 


Cash flows from financing activities

                

Net increase in short-term borrowings

     11,165       7,747  

Proceeds from long-term debt

     2,463       —    

Repayment of long-term debt

     (255 )     —    

Dividends paid

     (4,091 )     (3,924 )

Stock options exercised, other

     716       1,700  

Distributions to minority shareholders

     (245 )     (609 )
    


 


Net cash provided by financing activities

     9,753       4,914  
    


 


Effect of exchange rate changes on cash

     (818